+1,011.8%
MRNA vs ACM
+188.1%
+823.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ACM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | +11.1% | -15.0% | -6.7% |
| 7D | -17.6% | +14.0% | -31.6% | -20.6% |
| 30D | -5.1% | +36.6% | -41.8% | -12.8% |
| 3M | +220.8% | +30.1% | +190.7% | +199.3% |
| 6M | +321.7% | +14.0% | +307.7% | +300.6% |
| YTD | +601.3% | -14.1% | +615.4% | +596.8% |
| 1Y | +735.2% | -37.9% | +773.2% | +777.5% |
| 3Y | +170.5% | -4.1% | +174.6% | +166.7% |
| 5Y | -14.6% | +17.1% | -31.7% | -17.4% |
| All | +1,011.8% | +188.1% | +823.8% | +759.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ACM.
Daily Out/Under-Performance
Portfolio return minus ACM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ACM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling